Collegium Pharmaceutical, Inc (COLL) · Aug 13, 2026 · Other events

The buyback was known—now Collegium puts $50M to work

$50M ASR — $50M commitment; 1.56M shares initially delivered

Collegium converts an existing $150M authorization into a $50M ASR, immediately taking in roughly 4.8% of outstanding shares.

The direction was already known: Collegium had a $150 million buyback authorization. The July 2025 program runs through December 31, 2026, so the market already had a standing expectation that excess cash could be returned through repurchases.

Filing figureDetail
ASR value$50 million (ASR Agreement)
Initial shares delivered1,556,420 (ASR Agreement)
Initial shares as a share of 32.5M outstanding~4.8% (ASR Agreement)
Portion of the $150M authorizationOne-third (ASR Agreement)
Expected final settlementNo later than Q4 2026 (ASR Agreement)

The new information is execution, not a new capital-return strategy. Collegium is committing one-third of the authorization now and receiving roughly 80% of the expected shares upfront, based on the August 12 closing price of $25.70. The final share count will vary with the volume-weighted average price during the ASR term (ASR Agreement).

The net read is meaningful but not an expectation beat. The filing creates immediate share-count support and confirms management is willing to deploy cash, but it does not increase the previously authorized $150 million ceiling. With no earnings, guidance, or published market benchmark to beat, this is best classified as a partly anticipated buyback execution event rather than a surprise positive catalyst.

What to watch next

Final ASR settlement, no later than Q4 2026

Original filing on SEC EDGAR

More Collegium Pharmaceutical, Inc news

The buyback was known—now Collegium puts $50M to work | COLL Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.